Integrum receives market approval for OPRA[® in Israel]
Mölndal, Sweden – May 29, 2024 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has received market approval for the OPRA[®] Implant System in Israel.In March, Integrum entered a commercial agreement with AMI Technologies to Introduce the OPRA® Implant System to the Israeli market. With the market approval in place, AMI Technologies can now start providing OPRA® to hospitals in the region. "There is a large need for innovative products in the region, and we appreciate the rapid regulatory approval making it possible to soon offer our life-changing